The new ESC guidelines emphasise the relevance of a tailored, holistic treatment strategy, based on the individual risk assessment and patient preferences. Shared decision-making requires educating and empowering patients by encouraging active involvement in the therapeutic process using in-depth discussion with patients and an explanation of the benefits and risks of available treatment strategies. The choice of optimal management strategy still remains a challenge, especially among AF patients at the highest risk of stroke and bleeding and requires further research. Autumn Statement: Workers to pay less in national insurance – but rate cuts don't offset the freezing of personal tax thresholds Invited as an ‘international technical expert’ in a Duke University Evidence-based Practice Center report "Stroke Prevention in Atrial Fibrillation", in partnership with the Agency for Healthcare Research and Quality (AHRQ) (USA, 2011-12). A contributor to the US-led Antiplatelet- Academic Research Consortium (ARC) initiative (2015). Larsen TB, Skjøth F, Nielsen PB, Kjældgaard JN, Lip GY. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study. BMJ. 2016 Jun 16;353:i3189. doi: 10.1136/bmj.i3189.

Recently awarded National Institute for Health Research (NIHR) Senior Investigator status (2017-2020) in open competition. Sex - female sex gives one point; however, it is valid only in the presence of at least one other stroke risk factor. Potpara TS, Lip GYH, Blomstrom-Lundqvist C, et al. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost 2021;121:270–8.Martin Lewis: What the Autumn Statement means for you – including wages, benefits, pensions, ISAs, housing, national insurance and more Although there was no significant difference in age, patients non-adherent to the ABC pathway presented with more prevalent diabetes, heart failure, renal impairment, and vascular disease (both coronary and peripheral artery diseases), as well as with higher CHA 2DS 2-VASc and HAS-BLED scores, compared to adherent patients (Table 1). May 2016, HungarianSociety of Cardiology medal, Openingceremony and Honorary Membership lecture, Annual Scientific Congress of the HungarianSociety of Cardiology, Balatonfüred

Unless anyone want`s to contest this be content with the fact that you are now eligible!! HOORAH!!! Work into improving AF clinical management won the Heart Rhythm UK ‘Arrhythmia AllianceTeam of the Year Award 2012'and the BMJ Group ‘CardiovascularTeam of the Year 2013’ award Chao TF, Joung B, Takahashi Y, Lim TW, Choi EK, Chan YH, et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary. Thromb Haemost. 2022;122(1):20-47. Proietti M, Romiti GF, Olshansky B, Lane DA, Lip GYH. Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial. J Am Heart Assoc. 2020;9(10):e014932. A patient was considered as fully ABC pathway adherent (“ABC adherent care”) if all the three criteria were fulfilled. Follow-up and Clinical OutcomesApril 2015, delivered the Michaelides lecture, at the 30th International Meeting on Clinical Cardiology, organized by the Hellenic Heart Foundation; Athens, Greece Guo Y, Guo J, Shi X, et al. Mobile health technology-supported atrial fibrillation screening and integrated care: a report from the mAFA-II trial long-term extension cohort. Eur J Intern Med 2020;82:105–11. appointed Adjunct Professor in Aalborg University, Denmark – for research and teaching. Professor Lip also holds Visiting Chairs in Belgrade, Beijing, Leeds, Taiwan, China, etc – primarily for research leadership. Guo Y, Lane DA, Chen Y, Lip GYH. Regular bleeding risk assessment associated with reduction in bleeding outcomes: the mAFA-II randomized trial. Am J Med 2020;133:1195–202.e2.

Added directed letter: COVID-19 testing, Annex A to directed letter COVID-19 testing, directed letter on EU Exit and the Brexit delay form. Updated: Directed letter (update 1) - continuity of education allowance (CEA) - regulatory flexibility in response to coronavirus (COVID-19). Donaldson Field Airport covers an area of 1,300 acres (530ha) which contains one runway designated 5/23 with 8,000 x 150ft (2,438 x 46 m) concrete pavement. He was selected to the Thomson Reuters Science Watch list of ‘World’s Most Influential Scientific Minds 2014’, a ranking of today’s top 17 scholars who have published the greatest number of hot papers, ranked in the top 0.1% by citations, issued June 2014. In 2014, Professor Lip was ranked by Expertscapeas one of the world's leading experts in the understanding and treatment of AF. This global top ranking is still maintained in January 2018. Rivera-Caravaca JM, Marín F, Esteve-Pastor MA, Gálvez J, Lip GYH, Vicente V, et al. Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation. BMJ Open. 2019;9(12):e033712.Goette A, Merino JL, Ezekowitz MD, Zamoryakhin D, Melino M, Jin J, Mercuri MF, Grosso MA, Fernandez V, Al-Saady N, Pelekh N, Merkely B, Zenin S, Kushnir M, Spinar J, Batushkin V, de Groot JR, Lip GY. Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial. Lancet. 2016 Aug 26. pii: S0140-6736(16)31474-X. doi: 10.1016/S0140-6736(16)31474-X. This won`t affect me as I only moved into SFA Oct 06 and GYH(SA) under RAACs was superceded by JSP`s in Apr 06 so from Apr 06 to Dec 07 there was no entitlement. Removed Directed letter: UK private arrangements self-help scheme (UKPASH) in response to coronavirus (COVID-19), Theye decypher the "Reducing the impact of separation on Service personnel, and where applicable, thier immediate family" to mean that if Married Accompanied you are ineligible as you are not separated, however para 05.0204 Qualifying Residence says that "The QRes for the purpose of GYH Travel must be one of the following: a. The Familiy Home b. Privately Maintained Property. c. RWA (With some other criteria.